www.fdanews.com/articles/177377-nih-pharmacokinetic-profile-extending-technology-now-available
NIH: Pharmacokinetic-Profile Extending Technology Now Available
July 6, 2016
The National Institutes of Health has announced the commercial availability of a platform technology that extends the pharmacokinetic properties of certain classes of drugs.
According to a notice, the licensing offer benefits early-stage drugs and features other advantages such as eliminating renal clearance.
It has applicability to cancer drugs, diabetes drugs and central nervous system drugs.